VanEck Vectors Biotech ETF (BBH)

Delayed Data
As of 3:53pm ET
 +2.54 / +2.09%
Today’s Change
Today|||52-Week Range

Investment Objective

The investment seeks to replicate as closely as possible- before fees and expenses- the price and yield performance of the MVIS- US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

3 ETFs to Watch on Biotech Earnings
Feb 10 / - Paid Partner Content


1 month-7.77% 3 years-1.15%
3 months-1.96% 5 years+16.02%
1 year+3.25% Since inception+22.45%
Data through 02/23/2018

Quote Details

Previous close$121.36
Open day’s range121.60 – 123.90
Net asset value (NAV)121.49 (02/22/2018)
Daily volume43,549
Average volume (3 months)44,261
Data as of 3:53pm ET, 02/23/2018

Peer Comparisonvs. Health ETFs

Performance 5-yr return+16.02%+17.28%
Expense Gross exp ratio0.39%1.31%
Risk 5 year sharpe ratio0.861.11
Net assets$602.8M$3.2B
Average market cap$38.7B$9.5B
Average P/E20.122.6
Dividend / Share--0.34%


XLV Health Care Select Sector SPDR® Fund
RYH Guggenheim S&P 500® Equal Weight Health...
FHLC Fidelity® MSCI Health Care Index ETF


Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
AMGN Amgen11.93%
GILD Gilead Sciences11.56%
CELG Celgene8.47%
BIIB Biogen7.03%
AGN Allergan6.00%
VRTX Vertex Pharmaceuticals Inc5.33%
SHPG Shire4.89%
ALXN Alexion Pharmaceuticals Inc4.57%
ILMN Illumina Inc4.54%
IQV Iqvia Holdings Inc4.35%